Curewell agrees to acquire majority stake in ECA Medical

ECA Medical announced a definitive agreement for Curewell to buy a majority interest from LongueVue Capital. Management, led by Lane Hale, would continue running the business. The transaction was expected to close in the fourth quarter of 2026, subject to customary closing conditions. Its terms were not disclosed. This was an announced agreement, not a confirmed completed acquisition.